| Net Cash Provided by (Used in) Operating Activities |
$58,837,000 |
USD |
52% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$36,114,000 |
USD |
-35% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$308,000 |
USD |
9.4% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
35,423,000 |
shares |
516% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$134,656,000 |
USD |
52% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$3,217,000 |
USD |
-23% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,013,000 |
USD |
-52% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$21,271,221 |
USD |
-36% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$27,000 |
USD |
1250% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$115,350,517 |
USD |
105% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$143,000 |
USD |
72% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$5,289,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,927,557 |
USD |
-63% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$188,586,688 |
USD |
1.4% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$274,000 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$16,672,775 |
USD |
61% |
Q1 2024 |
Q1 2024 |